Sam Brusco, Associate Editor09.20.23
Moon Surgical, a French-American company developing collaborative robotics, has gained CE mark certification for the latest version of its Maestro system.
The updated Maestro has scalability and refined aesthetics. It also features automated setup with bedside guidance and tailored surgeon configurations, as well as cloud connectivity. Surgeon guided, hands-free scope control also offers optimized vision capabilities.
"This latest evolution of the Maestro System focuses on manufacturing scalability, together with increased capability and has simplified both usability and training," said Anne Osdoit, CEO of Moon Surgical, and a Partner at Sofinnova Partners, told the press. “It seamlessly integrates into OR workflows while giving surgeons more confidence and delivering an improved surgical experience.”
Moon Surgical aims to broaden the scale at which robotics are used, improve quality of care, and improve the bottom line for healthcare providers. The Maestro system was designed to offer an accessible, enhanced version of traditional laparoscopy to over 18 million patients undergoing soft tissue procedures annually, who currently lack the benefits of robotic surgical platforms.
The updated Maestro has scalability and refined aesthetics. It also features automated setup with bedside guidance and tailored surgeon configurations, as well as cloud connectivity. Surgeon guided, hands-free scope control also offers optimized vision capabilities.
"This latest evolution of the Maestro System focuses on manufacturing scalability, together with increased capability and has simplified both usability and training," said Anne Osdoit, CEO of Moon Surgical, and a Partner at Sofinnova Partners, told the press. “It seamlessly integrates into OR workflows while giving surgeons more confidence and delivering an improved surgical experience.”
Moon Surgical aims to broaden the scale at which robotics are used, improve quality of care, and improve the bottom line for healthcare providers. The Maestro system was designed to offer an accessible, enhanced version of traditional laparoscopy to over 18 million patients undergoing soft tissue procedures annually, who currently lack the benefits of robotic surgical platforms.